tisagenlecleucel
novartis
['elara', 'follicular', 'tisa-cel', 'lymphoma', 'lymsm', 'novartis']
presented at #ash21: in the pivotal phase 2 elara trial, tisa-cel #cartcells produced a high rate of complete responses with a manageable safety profile in adults with r/r follicular #lymphoma #lymsm #immunotherapy #ash22 
Nature Medicine is a research journal devoted to publishing the latest advances in translational and clinical research for scientists and physicians.